Venrock Associates Iv L P

Avg. Two Year Performance

(7%) Avg. Purchase Return
(3%) Compound
(432%) Avg. Sale Return
(131%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return11%32%(1%)(20%)(7%)
Purchase Success Rate2 of 42 of 41 of 40 of 41 of 4
Average Sale Return(9%)(14%)(26%)(86%)(432%)
Sale Success Rate2 of 32 of 31 of 30 of 30 of 3

Alimera Sciences Inc

Drugs » Drug Manufacturers - Major

10% Owner:

Holdings: 6.21M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Anacor Pharmaceuticals, Inc.

Other » Other

10% Owner:

Holdings: 3.58M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Acceleron Pharma Inc

Drugs » Biotechnology

10% Owner:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Achaogen, Inc.

Drugs » Biotechnology

10% Owner:

Holdings: 4.09M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Bellerophon Therapeutics, I...

Drugs » Biotechnology

10% Owner:

Holdings: 6.44M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

On Semiconductor Connectivi...

Other » Other

10% Owner:

Holdings: 11.48M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--